Skip to content

Funding Announcements

Filter

Filter & sort

Keyword

Tag

Round

Sort by

Clear

The latest funding rounds from the UK tech ecosystem. Updated 16 October 2026.

Announcements

503

Total raised

£3.8B

disclosed amounts

This month

£36.9M

raised so far

The funding was provided by o2h Ventures to back the University of Sussex spin out.

"We are delighted to be working with the University of Sussex and the founders to launch and grow Stingray Bio. We have been following the science for several years and we are now excited to support the commercialisation of the founder's research to develop new drugs for cancer."
— Sunil Shah, Co-Founder and Managing Partner
Series B
£8.7M

The health technology company has closed a £8.7m Series B investment backed by high-profile angel investors.

"Low-cost, non-invasive technology for monitoring blood to a high standard is a holy grail that has profound, life-enhancing impact – whether you are monitoring metabolic health to improve athletic performance, or working to reverse the trend towards diabetes. I’m delighted to be working on developing such transformative products based on Zedsen’s novel non-invasive technology and being part of Zedsen’s amazing team."
— Caroline Hargrove, CTO
Pre-Seed
£800K

Calm/Storm VC led the pre-seed round, which also saw participation from QVentures and an innovation grant from InnovateUK.

"Our mission at Béa is to democratise access to effective fertility treatments; providing people with more options. ICI is clinically proven to be highly effective when it comes to increasing the chances of conception, but it’s not made available to people at the beginning of their fertility journey. Instead, they have to take a big leap into the expensive world of invasive treatments. But for people where there’s no medically-identified issue causing infertility, ICI can be the ideal way of maximising their chances of getting pregnant. We’re designing a product that enables people to do this easily and affordably, all from home."
— Tess Cosad, CEO and co-founder
Series A
£21.9M

The Series A round featured participation from Sonoma Brands, Waldencast, Felix Capital, and Cherry Ventures.

"We’ve been encouraged to see men of all ages increasingly turning to Manual to solve multiple health problems, with almost half of our customers seeking help for more than one issue. It’s clear that a health concern may have more than one cause, and we can provide customers with the ability to treat their health in a more holistic way. Using different treatments to understand and improve their wellbeing."
— George Pallis, Founder and CEO
Seed
£530K

The digital health company raised the capital to scale its AI powered patient management platform and support remote care programmes.

"Greater Manchester is the only place in the UK that can provide us the data partnerships, research support, diverse population and integrated health and social care practices that will enable us to give healthcare professionals the control and trust in the unbiased intelligence that powers our patient management system."
— Anuj Saboo, CTO and co-founder